ResearcherAlbert Einstein College of MedicineActive in the last 2 years
Yvonne M. Saenger
Matched on ORCID iD 0000-0001-7074-2681; OpenAlex author ID A5078069424; NIH RePORTER profile ID 10309997. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 22
2017: 1 paper · 2018: none · 2019: none · 2020: 1 grant · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer. Last author DOI 10.1093/oncolo/oyae200↗
- Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-Wo… Co-author DOI 10.1093/oncolo/oyac217↗
- Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma. Last author DOI 10.1080/2162402x.2022.2066767↗
- Current and Emerging Therapies in Metastatic Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-16-2319↗
Grants 1
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gulam Abbas Manji · 4 shared papers, 2017–2025 · strength 0.64
- Paper Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer. DOI 10.1093/oncolo/oyae200↗
- Paper Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regre… DOI 10.1093/oncolo/oyac217↗
- Paper Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma. DOI 10.1080/2162402x.2022.2066767↗
- Karie D. Runcie · 1 shared paper, 2025 · strength 0.28
- Tamas A. Gonda · 1 shared paper, 2025 · strength 0.28
- Susan Elaine Bates · 2 shared papers, 2022–2023 · strength 0.26
- John A. Chabot · 2 shared papers, 2022–2023 · strength 0.26
- Marc Ychou · 1 shared paper, 2023 · strength 0.15
- Thierry Conroy · 1 shared paper, 2023 · strength 0.15
- Keith Magnus Sigel · 1 shared paper, 2023 · strength 0.15
- Gayle Jameson · 1 shared paper, 2023 · strength 0.15
- Celine Yeh · 1 shared paper, 2023 · strength 0.15
- Rachael Ann Safyan · 1 shared paper, 2023 · strength 0.15
- Elizabeth M. Hecht · 1 shared paper, 2023 · strength 0.15
- Tito Fojo · 1 shared paper, 2023 · strength 0.15
- Daniel D. Von Hoff · 1 shared paper, 2023 · strength 0.15
- Raúl Rabadán · 1 shared paper, 2022 · strength 0.11
- David Paul Horowitz · 1 shared paper, 2022 · strength 0.11
- Thomas Enzler · 1 shared paper, 2022 · strength 0.11
- Robyn D. Gartrell · 1 shared paper, 2022 · strength 0.11
- Michael D. Kluger · 1 shared paper, 2022 · strength 0.11
- Beth Schrope · 1 shared paper, 2022 · strength 0.11
- Kenneth P. Olive · 1 shared paper, 2017 · strength 0.10
- Paul E. Oberstein · 1 shared paper, 2017 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.